ZA200705824B - Therapeutic nutrient compositions or combinations comprising a glutamine-containing short chain peptide and an antioxidant - Google Patents

Therapeutic nutrient compositions or combinations comprising a glutamine-containing short chain peptide and an antioxidant

Info

Publication number
ZA200705824B
ZA200705824B ZA200705824A ZA200705824A ZA200705824B ZA 200705824 B ZA200705824 B ZA 200705824B ZA 200705824 A ZA200705824 A ZA 200705824A ZA 200705824 A ZA200705824 A ZA 200705824A ZA 200705824 B ZA200705824 B ZA 200705824B
Authority
ZA
South Africa
Prior art keywords
glutamine
antioxidant
combinations
short chain
chain peptide
Prior art date
Application number
ZA200705824A
Other languages
English (en)
Inventor
Daren K Heyland
Original Assignee
Critical Care Connections Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Critical Care Connections Inc filed Critical Critical Care Connections Inc
Publication of ZA200705824B publication Critical patent/ZA200705824B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200705824A 2004-12-21 2005-12-21 Therapeutic nutrient compositions or combinations comprising a glutamine-containing short chain peptide and an antioxidant ZA200705824B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63765704P 2004-12-21 2004-12-21

Publications (1)

Publication Number Publication Date
ZA200705824B true ZA200705824B (en) 2008-12-31

Family

ID=36601322

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200705824A ZA200705824B (en) 2004-12-21 2005-12-21 Therapeutic nutrient compositions or combinations comprising a glutamine-containing short chain peptide and an antioxidant

Country Status (9)

Country Link
US (1) US20080131525A1 (de)
EP (1) EP1841445A4 (de)
JP (2) JP2008524123A (de)
CN (1) CN101084003A (de)
AU (1) AU2005318832B2 (de)
BR (1) BRPI0519755A2 (de)
CA (1) CA2588911C (de)
WO (1) WO2006066404A1 (de)
ZA (1) ZA200705824B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014264537B2 (en) 2013-05-08 2018-10-18 Gambro Lundia Ab Dialysis formulation
CA3032398A1 (en) * 2016-08-01 2018-02-08 Filament Biosolutions Inc. Methods of treating and preventing cancer treatment side effects
GB201811312D0 (en) * 2018-07-10 2018-08-29 Nuchido Ltd Compositions

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294520B1 (en) * 1989-03-27 2001-09-25 Albert T. Naito Material for passage through the blood-brain barrier
DE4304172A1 (de) * 1993-02-12 1994-08-25 Bayer Ag Fungizide Wirkstoffkombinationen
US5561111A (en) * 1994-12-23 1996-10-01 The University Of Virginia Patent Foundation Stable glutamine derivatives for oral and intravenous rehydration and nutrition therapy
US6022867A (en) * 1996-11-27 2000-02-08 Showa Denko Kabushiki Kaisha Method of administering vitamin E to animals and compositions containing tocopheryl phosphates and salts thereof for animals
CA2276183C (en) * 1996-12-31 2009-06-09 Antioxidant Pharmaceuticals Corporation Pharmaceutical preparations of glutathione and methods of administration thereof
US5849335A (en) * 1997-06-02 1998-12-15 Nestec S.A. Composition and method for providing glutamine
ATE555780T1 (de) * 1997-10-24 2012-05-15 John P Blass Nahrungsergänzungsmittel für metabolische hirnleistungsstörungen
AU4251300A (en) * 1999-05-07 2000-11-21 University Of Virginia Patent Foundation Biological production of stable glutamine, poly-glutamine derivatives in transgenic organisms and their use for therapeutic purposes
US6805880B1 (en) * 1999-08-20 2004-10-19 Ferrosan A/S Pharmaceutical delivery system for vitamin C and vitamin E and use of a combination of vitamin C and E for preventing or treating conditions involving oxidative stress
US6890896B1 (en) * 1999-11-18 2005-05-10 Ceremedix, Inc. Compositions and methods for counteracting effects of reactive oxygen species and free radicals
CN1423528A (zh) * 2000-04-18 2003-06-11 雀巢制品公司 营养单元
US6479068B1 (en) * 2000-06-30 2002-11-12 Baxter International Inc. Therapeutic nutrient regimen for alleviating mucositis, stomatitis and cachexia in oncology patients
DE10057290B4 (de) * 2000-11-17 2004-01-08 Fresenius Kabi Deutschland Gmbh Enteral zu verabreichendes Supplement zur parenteralen Ernährung oder partiellen enteralen/oralen Ernährung bei kritisch Kranken, chronisch Kranken und Mangelernährten
WO2002048092A2 (en) * 2000-12-15 2002-06-20 Mitokor Compounds for altering mitochondrial function and cellular responses
WO2002071874A2 (en) * 2001-03-09 2002-09-19 Societe Des Produits Nestle S.A. Composition improving age-related physiological deficits and increasing longevity
US6660293B2 (en) * 2001-06-29 2003-12-09 Everett Laboratories, Inc. Compositions and methods for prophylactic and therapeutic supplementation of nutrition in subjects
DE10151764A1 (de) * 2001-10-19 2003-05-08 Basf Ag Kombination von Liponsäure und Glutamin in Lebens- und Arzneimitteln
JP2003192586A (ja) * 2001-12-27 2003-07-09 Ss Pharmaceut Co Ltd ＩＬ−１β抑制剤
DE10221403A1 (de) * 2002-05-14 2003-12-04 Kyberg Pharma Vertriebs Gmbh & Diätetische und pharmazeutische Zusammensetzungen, ihre Herstellung und ihre Verwendung
US6645514B1 (en) * 2002-12-19 2003-11-11 Access Business Group International, Llc Increasing skin cell renewal with water-soluble Vitamin E

Also Published As

Publication number Publication date
BRPI0519755A2 (pt) 2009-03-10
CA2588911C (en) 2013-04-23
AU2005318832A1 (en) 2006-06-29
CA2588911A1 (en) 2006-06-29
CN101084003A (zh) 2007-12-05
EP1841445A1 (de) 2007-10-10
EP1841445A4 (de) 2010-06-02
AU2005318832B2 (en) 2011-07-07
JP2008524123A (ja) 2008-07-10
JP2012107023A (ja) 2012-06-07
US20080131525A1 (en) 2008-06-05
WO2006066404A1 (en) 2006-06-29

Similar Documents

Publication Publication Date Title
TWI369981B (en) Hmb compositions and uses thereof
EP1737050A4 (de) Lichtquelle und beleuchtungseinrichtung
EP1797891A4 (de) Totale enterale nahrungszusammensetzung
EP1799213A4 (de) Neue curcuminanaloge und verwendungen dafür
EP1827289A4 (de) Implantat und implantatelement
AU2003296357A8 (en) Compositions and methods for nutrition supplementation
GB0411940D0 (en) Methods and compositions
EP1701725A4 (de) Verfahren und zusammensetzungen
TWI317738B (en) Tripeptide and tetrapeptide thioethers
ZA200706128B (en) Pesticide compositions and methods
EP1814977A4 (de) Zusammensetzungen auf arthrospira-basis und verwendungen davon
EP1737458A4 (de) R(-)-11-hydroxyaporphinderivate und ihre verwendung
EP1656148A4 (de) Mikronährstoff-ergänzung
HK1105357A1 (zh) 腸營養物
SI1776298T1 (sl) Transportni trak in transporter, obsegajoč tovrsten trak
EP1640429A4 (de) Lichtemittierende vorrichtung und nachleuchtender leuchtstoff
PL1940818T3 (pl) Pochodne aminokwasów zawierające grupę disulfanylową jako mieszane inhibitory neprylizyny i aminopeptydazy n
ZA200705824B (en) Therapeutic nutrient compositions or combinations comprising a glutamine-containing short chain peptide and an antioxidant
EP1789037A4 (de) Magentherapien und zusammensetzungen dafür
GB2411396B (en) Aeration pond and reedbed
AU2003272717A8 (en) Frozen spermatozoa compositions and uses thereof
GB0215240D0 (en) Multi-way puzzles
EP1699809A4 (de) Amniotisches peptid und anwendungen davon
HU0300199V0 (en) Amosing and thdught-provoking game
AU2003282339A8 (en) Game pieces and game